Predictive value of epstein-barr virus genome copy number and BZLF1 expression in blood lymphocytes of transplant recipients at risk for lymphoproliferative disease

Journal of Infectious Diseases

Volumn 181, Issue 6, 2000, Pages 2050-2054

  Vajro, Pietro ^a   Lucariello, Stefania ^a   Migliaro, Fiorella ^a   Sokal, Etienne ^b   Gridelli, Bruno ^c   Vegnente, Angela ^a   Iorio, Raffaele ^a   Smets, Françoise ^b   Quinto, Ileana ^a   Scala, Giuseppe ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c OSPEDALI RIUNITI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; COMPLEMENTARY DNA; CYCLOSPORIN A; VIRUS RNA;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; EPSTEIN BARR VIRUS; FEMALE; GENE EXPRESSION; HUMAN; LIVER TRANSPLANTATION; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MALE; MONONUCLEAR CELL; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRESCHOOL CHILD; PRIORITY JOURNAL; RNA ANALYSIS; SCHOOL CHILD; VIRUS GENOME; VIRUS PATHOGENESIS;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; GENE DOSAGE; GENOME, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; LIVER TRANSPLANTATION; LYMPHOCYTES; LYMPHOPROLIFERATIVE DISORDERS; MALE; RISK; RNA, MESSENGER; TRANS-ACTIVATORS; VIRAL PROTEINS;

EID: 0034046928     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/315495     Document Type: Article

References (15)

1. 1. Nalesnick MA. Clinicopathologic features of posttransplant lymphoproliferative disorders. Ann Transplant 1997;2:33-40.
2. 2. Sokal EM, Antunes H, Beguin C, et al. Early signs and risk factors for the increased incidence of EBV-related posttransplant lymphoproliferative diseases in pediatric liver transplant recipients treated with tacrolimus. Transplantation 1997;64:1438-42.
3. 3. Riddler SA, Breining MC, McKnight JLC. Increased levels of circulating EBV infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid organ transplant recipients. Blood 1994;84: 972-84.
4. 4. Lucas KG, Burton RL, Zimmerman SE, et al. Semiquantitative Epstein-Barr virus (EBV) polymerase chain reaction for the determination of patients at risk for EBV induced lymphoproliferative disease after stem cell transplantation. Blood 1998;91:3654-61.
5. 5. Lucas KG, Filo F, Heilman DK, Lee CH, Emanuel DJ. Semiquantitative Epstein-Barr virus polymerase chain reaction analysis of peripheral blood from organ transplant patients and risk for development of lymphoproliferative disease. Blood 1998;92:3977-8.
6. 6. Miller G. The switch between latency and replication of Epstein-Barr virus. J Infect Dis 1990;161:833-44.
7. 7. Gradoville L, Grogan E, Taylor N, Miller G. Differences in the extent of activation of Epstein-Barr virus replicative gene expression among four nonproducer cell lines stably transformed by oriP/BZLFI plasmids. Virology 1990;178:345-54.
8. 8. Sokal EM, Caragiozoglou T, Lamy M, Reding R, Otte JB. Epstein-Barr virus serology and Epstein-Barr virus associated lymphoproliferative disorders in pediatric liver transplant recipients. Transplantation 1993;56:1394-8.
9. 9. Flemington E, Speck SH. Identification of phorbol ester response elements in the promoter of Epstein-Barr virus putative lytic switch gene BZLFI. J Virol 1990;64:1217-26.
10. 10. Telenti A, Marshall WF, Smith TF. Detection of EBV by polymerase chain reaction. J Clin Microbiol 1990;28:2187-90.
11. 11. Rea D, Fourcade C, Leblond V, et al. Patterns of EBV latent and replicative gene expression in EBV B cell lymphoproliferative disorders after organ transplantation. Transplantation 1994;58:317-24.
12. 12. Montone KT, Hodinka RL, Salhany KE, Lavi E, Rostami A, Tomaszewski JE. Identification of Epstein-Barr virus lytic activity in post-transplantation lymphoproliferative disease. Mod Pathol 1996;9:621-30.
13. 13. Prang NS, Hornef MW, Jager N, et al. Lytic replication of EBV in the peripheral blood: analysis of viral gene expression in B lymphocytes during infectious mononucleosis and in the normal carrier state. Blood 1997;89: 1665-7.
14. 14. Tao Q. Epstein-Barr virus lytic infection in lymphocytes and the persistence of the virus. Blood 1997;90:2114-6.
15. 15. Drouet E, Brousset P, Fares F, et al. High Epstein-Barr virus serum load and elevated titers of anti-ZEBRA antibodies in patients with EBV-harboring tumor cells of Hodgkin's disease. J Med Virol 1999;57:383-9.